Analyze Diet
Clinical and diagnostic laboratory immunology2004; 11(6); 1120-1129; doi: 10.1128/CDLI.11.6.1120-1129.2004

Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.

Abstract: We recently reported a highly protective attenuated live virus vaccine for equine infectious anemia virus (EIAV) based on a proviral construct (EIAVUKDeltaS2) with a genetically engineered mutation in the viral S2 gene that eliminates expression of this accessory protein. While the EIAVUKDeltaS2 vaccine provides protection from detectable infection by experimental challenge with highly virulent virus, the potential for commercial application of this vaccine is complicated by the fact that horses inoculated with the EIAVUKDeltaS2 vaccine strain become seropositive in various reference diagnostic assays based on detection of antibodies to virion core or envelope proteins. To address this issue, we describe here the development and optimization of a new serologic EIAV diagnostic enzyme-linked immunosorbent assay (ELISA) to detect serum antibodies to the EIAV S2 protein that are produced in infected horses but not in horses inoculated with the EIAVUKDeltaS2 vaccine virus. The test S2 protein antigen was developed using the S2 gene sequence from the EIAVUK strain of virus and a series of modifications to facilitate production and purification of the diagnostic antigen, designated HS2G. Using this HS2G as antigen, we describe the development of an affinity ELISA that provides a sensitive and specific detection of S2-specific serum antibodies in experimentally and field-infected horses (22 of 24), without detectable reactivity with immune serum from uninfected (12 of 12) or vaccinated (29 of 29) horses. These data indicate that the S2-based diagnostic ELISA has the potential to accurately differentiate horses infected with EIAV from horses inoculated with an attenuated EIAV vaccine strain with a mutant S2 gene.
Publication Date: 2004-11-13 PubMed ID: 15539516PubMed Central: PMC524783DOI: 10.1128/CDLI.11.6.1120-1129.2004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the creation and use of a serological method using a recombinant S2 protein that can differentiate between horses infected with equine infectious anemia virus (EIAV) and horses that have been vaccinated against EIAV.

Background of the Study

  • The research team has previously reported an effective live virus vaccine for EIAV, based on a genetic mutation in the S2 gene of the virus.
  • This mutation eliminates the expression of the S2 accessory protein which assists the virus in infecting the host.
  • However, the use of this vaccine creates a challenge because horses inoculated with it show seropositive results in various diagnostic assays. These assays detect antibodies produced in response to the viral core or envelope proteins, thereby failing to differentiate between vaccinated and infected horses.

Development of a New Diagnostic Method

  • To address the challenge, the research team developed a new diagnostic method based on an enzyme-linked immunosorbent assay (ELISA) that recognizes antibodies to the EIAV S2 protein. This protein is produced in horses infected by EIAV, but not in horses vaccinated with the altered virus.
  • The diagnostic antigen used in this test, designated as HS2G, is produced using the S2 gene sequence from the EIAVUK strain of the virus, with modifications to facilitate its production and purification.

Results of the Study

  • Through the use of this new diagnostic ELISA, the team was able to detect S2-specific serum antibodies in almost all experimentally and field-infected horses (22 out of 24).
  • Moreover, the test showed no reactivity with the serum from uninfected (12 out of 12) or vaccinated (29 out of 29) horses.

Conclusion

  • The research concluded that the newly developed S2-based diagnostic ELISA has the potential to accurately differentiate horses infected with EIAV from those inoculated with the mutant EIAV vaccine strain.
  • Thus, this new assay might be a beneficial tool in differentiating between vaccinated and infected horses in the context of disease surveillance and control.

Cite This Article

APA
Jin S, Issel CJ, Montelaro RC. (2004). Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses. Clin Diagn Lab Immunol, 11(6), 1120-1129. https://doi.org/10.1128/CDLI.11.6.1120-1129.2004

Publication

ISSN: 1071-412X
NlmUniqueID: 9421292
Country: United States
Language: English
Volume: 11
Issue: 6
Pages: 1120-1129

Researcher Affiliations

Jin, Sha
  • Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Issel, Charles J
    Montelaro, Ronald C

      MeSH Terms

      • Animals
      • Antibodies, Viral / blood
      • Enzyme-Linked Immunosorbent Assay / methods
      • Equine Infectious Anemia / diagnosis
      • Equine Infectious Anemia / prevention & control
      • Horses
      • Infectious Anemia Virus, Equine / genetics
      • Infectious Anemia Virus, Equine / immunology
      • Predictive Value of Tests
      • Viral Proteins / genetics
      • Viral Proteins / immunology
      • Viral Vaccines / administration & dosage
      • Viral Vaccines / genetics
      • Viral Vaccines / immunology

      Grant Funding

      • R01 AI025850 / NIAID NIH HHS
      • R01 AI25850 / NIAID NIH HHS

      References

      This article includes 33 references
      1. Archambault D, Wang ZM, Lacal JC, Gazit A, Yaniv A, Dahlberg JE, Tronick SR. Development of an enzyme-linked immunosorbent assay for equine infectious anemia virus detection using recombinant Pr55gag.. J Clin Microbiol 1989 Jun;27(6):1167-73.
      2. Ball JM, Rushlow KE, Issel CJ, Montelaro RC. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.. J Virol 1992 Feb;66(2):732-42.
        pmc: PMC240772pubmed: 1370556doi: 10.1128/jvi.66.2.732-742.1992google scholar: lookup
      3. Birkett AJ, Yélamos B, Rodríguez-Crespo I, Gavilanes F, Peterson DL. Cloning, expression, purification, and characterization of the major core protein (p26) from equine infectious anemia virus.. Biochim Biophys Acta 1997 Apr 25;1339(1):62-72.
        pubmed: 9165100doi: 10.1016/s0167-4838(96)00215-4google scholar: lookup
      4. Carroll R, Derse D. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.. J Virol 1993 Mar;67(3):1433-40.
      5. Coggins L, Norcross NL. Immunodiffusion reaction in equine infectious anemia.. Cornell Vet 1970 Apr;60(2):330-5.
        pubmed: 4986043
      6. Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.. J Virol 1998 Feb;72(2):1383-93.
      7. Fuerst TR, Niles EG, Studier FW, Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.. Proc Natl Acad Sci U S A 1986 Nov;83(21):8122-6.
        pmc: PMC386879pubmed: 3095828doi: 10.1073/pnas.83.21.8122google scholar: lookup
      8. Hammond SA, Cook SJ, Falo LD Jr, Issel CJ, Montelaro RC. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.. Virology 1999 Feb 1;254(1):37-49.
        pubmed: 9927572doi: 10.1006/viro.1998.9550google scholar: lookup
      9. Hammond SA, Li F, McKeon BM Sr, Cook SJ, Issel CJ, Montelaro RC. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.. J Virol 2000 Jul;74(13):5968-81.
      10. Henderson LE, Sowder RC, Smythers GW, Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.. J Virol 1987 Apr;61(4):1116-24.
      11. Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, Montelaro RC. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.. J Virol 1987 Oct;61(10):2956-61.
      12. Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.. Arch Virol 1988;98(3-4):213-24.
        pubmed: 2450529doi: 10.1007/bf01322170google scholar: lookup
      13. Issel CJ, Adams WV Jr. Detection of equine infectious anemia virus in a horse with an equivocal agar gel immunodiffusion test reaction.. J Am Vet Med Assoc 1982 Feb 1;180(3):276-8.
        pubmed: 6276354
      14. Issel CJ, Coggins L. Equine infectious anemia: current knowledge.. J Am Vet Med Assoc 1979 Apr 1;174(7):727-33.
        pubmed: 218920
      15. Issel CJ, Cook RF. A review of techniques for the serologic diagnosis of equine infectious anemia.. J Vet Diagn Invest 1993 Jan;5(1):137-41.
        pubmed: 8385498doi: 10.1177/104063879300500136google scholar: lookup
      16. Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.. J Virol 1992 Jun;66(6):3398-408.
      17. Knowles DP Jr, Gorham JR. Advances in the diagnosis of some parasitic diseases by monoclonal antibody-based enzyme-linked immunosorbent assays.. Rev Sci Tech 1993 Jun;12(2):425-33.
        pubmed: 8400383doi: 10.20506/rst.12.2.692google scholar: lookup
      18. Kong XG, Pang H, Sugiura T, Sentsui H, Onodera T, Matsumoto Y, Akashi H. Application of equine infectious anemia virus core proteins produced in a baculovirus expression system to serological diagnosis.. Microbiol Immunol 1997;41(12):975-80.
      19. Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.. J Virol 2003 Jul;77(13):7244-53.
      20. Li F, Leroux C, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.. J Virol 2000 Jan;74(1):573-9.
      21. Li F, Puffer BA, Montelaro RC. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro.. J Virol 1998 Oct;72(10):8344-8.
      22. Mia AS, Tierney MM, Krevcak DM. Detection of equine infectious anemia antibody by a rapid microenzyme linked immunosorbent assay (ELISA). Proc. Annu. Meet. Am. Assoc. Vet. Lab. Diagn. 25:159-166.
      23. Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.. J Gen Virol 1988 Jul;69 ( Pt 7):1711-7.
        pubmed: 2839603doi: 10.1099/0022-1317-69-7-1711google scholar: lookup
      24. Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. Equine retroviruses, vol. 2. .
      25. Raabe ML, Issel CJ, Cook SJ, Cook RF, Woodson B, Montelaro RC. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.. Virology 1998 May 25;245(1):151-62.
        pubmed: 9614876doi: 10.1006/viro.1998.9142google scholar: lookup
      26. Raabe ML, Issel CJ, Montelaro RC. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.. Virology 1999 Jul 5;259(2):416-27.
        pubmed: 10388665doi: 10.1006/viro.1999.9772google scholar: lookup
      27. Reischl U. Application of molecular biology-based methods to the diagnosis of infectious diseases.. Front Biosci 1996 Aug 1;1:e72-7.
        pubmed: 9159247doi: 10.2741/a145google scholar: lookup
      28. Schiltz RL, Shih DS, Rasty S, Montelaro RC, Rushlow KE. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.. J Virol 1992 Jun;66(6):3455-65.
      29. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus.. Virus Res 1994 May;32(2):111-38.
        pmc: PMC7134051pubmed: 8067050doi: 10.1016/0168-1702(94)90038-8google scholar: lookup
      30. Shane BS, Issel CJ, Montelaro RC. Enzyme-linked immunosorbent assay for detection of equine infectious anemia virus p26 antigen and antibody.. J Clin Microbiol 1984 Mar;19(3):351-5.
        pmc: PMC271063pubmed: 6325488doi: 10.1128/jcm.19.3.351-355.1984google scholar: lookup
      31. Soutullo A, Verwimp V, Riveros M, Pauli R, Tonarelli G. Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides.. Vet Microbiol 2001 Mar 20;79(2):111-21.
        pubmed: 11230933doi: 10.1016/s0378-1135(00)00352-7google scholar: lookup
      32. Suzuki T, Ueda S, Samejima T. Enzyme-linked immunosorbent assay for diagnosis of equine infectious anemia.. Vet Microbiol 1982 Sep;7(4):307-15.
        pubmed: 6817506doi: 10.1016/0378-1135(82)90010-4google scholar: lookup
      33. Wang SZ, Rushlow KE, Issel CJ, Cook RF, Cook SJ, Raabe ML, Chong YH, Costa L, Montelaro RC. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.. Virology 1994 Feb 15;199(1):247-51.
        pubmed: 8116252doi: 10.1006/viro.1994.1120google scholar: lookup

      Citations

      This article has been cited 8 times.
      1. Yaakob Y, Rodrigues KF, Opook F, William T, John DV. Recombinant LipL32 Protein Developed Using a Synthetic Gene Detects Leptospira-specific Antibodies in Human Serum Samples.. Malays J Med Sci 2017 Oct;24(5):44-51.
        doi: 10.21315/mjms2017.24.5.5pubmed: 29386971google scholar: lookup
      2. Lei H, Jin S, Karlsson E, Schultz-Cherry S, Ye K. Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.. J Immunol Res 2016;2016:4131324.
        doi: 10.1155/2016/4131324pubmed: 28078309google scholar: lookup
      3. Jin S, Yao H, Weber JL, Melkoumian ZK, Ye K. A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells.. PLoS One 2012;7(11):e50880.
        doi: 10.1371/journal.pone.0050880pubmed: 23226418google scholar: lookup
      4. Yao H, Jin S. Enhancement of probe signal for screening of HIV-1 protease inhibitors in living cells.. Sensors (Basel) 2012 Dec 6;12(12):16759-70.
        doi: 10.3390/s121216759pubmed: 23223077google scholar: lookup
      5. Jin S, Yao H, Krisanarungson P, Haukas A, Ye K. Porous membrane substrates offer better niches to enhance the Wnt signaling and promote human embryonic stem cell growth and differentiation.. Tissue Eng Part A 2012 Jul;18(13-14):1419-30.
        doi: 10.1089/ten.TEA.2011.0474pubmed: 22429220google scholar: lookup
      6. Jin S, Ellis E, Veetil JV, Yao H, Ye K. Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe.. Biotechnol Prog 2011 Jul;27(4):1107-14.
        doi: 10.1002/btpr.628pubmed: 21584951google scholar: lookup
      7. Zhang B, Sun C, Jin S, Cascio M, Montelaro RC. Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding.. J Virol 2008 Feb;82(3):1204-13.
        doi: 10.1128/JVI.01393-07pubmed: 18032504google scholar: lookup
      8. Jin S, Chen C, Montelaro RC. Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production.. J Virol 2005 Jul;79(14):8793-801.